Amino acids and their roles in tumor immunotherapy of breast cancer
Hongzhuo Xia,Jianyu Zhu,Zhuomeng Zheng,Peiyao Xiao,Xiaohui Yu,Muyao Wu,Lian Xue,Xi Xu,Xinyu Wang,Yuxuan Guo,Chanjuan Zheng,Siyu Ding,Yian Wang,Xiaoning Peng,Shujun Fu,Junjun Li,Xiyun Deng
DOI: https://doi.org/10.1002/jgm.3647
Abstract:Breast cancer is the most commonly diagnosed cancer among women. The primary treatment options include surgery, radiotherapy, chemotherapy, targeted therapy and hormone therapy. The effectiveness of breast cancer therapy varies depending on the stage and aggressiveness of the cancer, as well as individual factors. Advances in early detection and improved treatments have significantly increased survival rates for breast cancer patients. Nevertheless, specific subtypes of breast cancer, particularly triple-negative breast cancer, still lack effective treatment strategies. Thus, novel and effective therapeutic targets for breast cancer need to be explored. As substrates of protein synthesis, amino acids are important sources of energy and nutrition, only secondly to glucose. The rich supply of amino acids enables the tumor to maintain its proliferative competence through participation in energy generation, nucleoside synthesis and maintenance of cellular redox balance. Amino acids also play an important role in immune-suppressive microenvironment formation. Thus, the biological effects of amino acids may change unexpectedly in tumor-specific or oncogene-dependent manners. In recent years, there has been significant progress in the study of amino acid metabolism, particularly in their potential application as therapeutic targets in breast cancer. In this review, we provide an update on amino acid metabolism and discuss the therapeutic implications of amino acids in breast cancer.